Stockscreener 앱 받기
2.55
0.00%
0.00
시간 외 거래:
2.56
0.01
+0.39%
전일 마감가:
$2.55
열려 있는:
$2.56
하루 거래량:
25,514
Relative Volume:
0.70
시가총액:
$77.74M
수익:
$300.00K
순이익/손실:
$-45.54M
주가수익비율:
-1.7071
EPS:
-1.4938
순현금흐름:
$-40.21M
1주 성능:
+1.19%
1개월 성능:
+9.91%
6개월 성능:
+6.69%
1년 성능:
-8.27%
1일 변동 폭
$2.54
$2.57
1주일 범위
$2.50
$2.58
52주 변동 폭
$2.09
$3.61
Xbiotech Inc Stock (XBIT) Company Profile
명칭
Xbiotech Inc
전화
512-386-2900
주소
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.55 | 77.74M | 300.00K | -45.54M | -40.21M | -1.4938 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-06-14 | 개시 | Piper Jaffray | Overweight |
| 2017-04-21 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-06-28 | 재확인 | Noble Financial | Buy |
Xbiotech Inc 주식(XBIT)의 최신 뉴스
XBiotech (XBIT) Projected to Post Earnings on Tuesday - MarketBeat
XBIT (XBiotech) reports zero Q1 2020 EPS missing estimates, shares dip 0.78 percent amid investor concern. - Newser
XBiotech Inc. 2025 Executive Compensation, Board Structure, and Shareholder Ownership Overview - Minichart
Executive pay and governance detailed in XBiotech (NASDAQ: XBIT) 10-K/A - Stock Titan
XBIT Should I Buy - Intellectia AI
XBIT (XBiotech Inc.) reports 100 percent Q1 2020 EPS miss, while shares notch mild gains on upbeat investor sentiment.Dividend Cut Risk - Xã Thanh Hà
XBiotech (XBIT) Stock: Price Action Overview (Smart Money Active) 2026-04-18Stock Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
Short Interest in XBiotech Inc. (NASDAQ:XBIT) Grows By 21.3% - MarketBeat
Aug PostEarnings: Is XBiotech Inc part of any major index2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn
Why is XBiotech (XBIT) Stock underperforming the market | Price at $2.33, Down 0.21%Trending Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Insider Buy: Is XBiotech Inc stock risky to hold nowMarket Performance Summary & Capital Efficiency Focused Strategies - baoquankhu1.vn
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageShould You Sell? - MarketBeat
CEO Moves: Is XBiotech Inc likely to announce a buybackShare Buyback & Risk Managed Investment Signals - baoquankhu1.vn
Is XBiotech (XBIT) Stock Worth Holding | Price at $2.38, Up 1.28%Market Expert Watchlist - Newser
Winners Losers: Can XBiotech Inc lead its sector in growth2026 Earnings Surprises & Growth Focused Entry Point Reports - baoquankhu1.vn
XBIT Stock Analysis: XBiotech Inc. at $2.34, mild 0.43% dip amid biotech sector activity - Newser
Wolverine World Wide Stock: Navigating Challenges in the Competitive Footwear Sector for Long-Term V - AD HOC NEWS
Published on: 2026-03-31 08:55:40 - baoquankhu1.vn
Are short sellers targeting XBiotech (XBIT) Stock | Price at $2.28, Down 2.15%Shared Trade Alerts - Newser
Stock List: Research Stocks from Around the World - GuruFocus
XBiotech Inc stock faces biotech sector headwinds amid pipeline uncertainty and market volatility - AD HOC NEWS
Comparing XBiotech (NASDAQ:XBIT) & IN8bio (NASDAQ:INAB) - Defense World
If You Invested $1,000 in Xbiotech (XBIT) - Stock Titan
Bearish Setup: Does XBiotech Inc offer margin of safetyWeekly Trade Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Setup Watch: Why is XBiotech Inc stock going down2026 Selloffs & Real-Time Stock Movement Alerts - baoquankhu1.vn
Wolverine World Wide Stock (ISIN: US9840001002) Faces Headwinds Amid Footwear Market Shifts - AD HOC NEWS
XBiotech (NASDAQ:XBIT) Stock Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
XBiotech Inc. 2025 Annual Report: Risks, Regulatory Challenges, and Competitive Landscape in True Human™ Antibody Drug Development - Minichart
XBiotech: Q4 Earnings Snapshot - marketscreener.com
XBiotech (NASDAQ: XBIT) details IL‑1α pipeline and cash use - Stock Titan
XBiotech 2025 10-K: $0.0M Revenue, $(1.49) EPS - TradingView
XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Gains Recap: Is Kulicke and Soffa Industries Inc in accumulation or distribution phaseQuarterly Investment Review & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Gainers Report: Can DECK keep up with sector leadersJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
Aug Sentiment: Is XBiotech Inc likely to announce a buybackQuarterly Market Summary & Free Verified High Yield Trade Plans - baoquankhu1.vn
XBIT SEC FilingsXbiotech 10-K, 10-Q, 8-K Forms - Stock Titan
XBIT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Does XBiotech Inc. offer margin of safetyJuly 2025 Big Picture & Real-Time Buy Zone Alerts - mfd.ru
What’s next for XBiotech Inc. stockJuly 2025 News Drivers & Reliable Momentum Entry Alerts - mfd.ru
Market Review: Can CASI Pharmaceuticals Inc maintain its current growth rateWeekly Investment Recap & Reliable Price Breakout Alerts - baoquankhu1.vn
XBIT PE Ratio & Valuation, Is XBIT Overvalued - Intellectia AI
XBIT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Should I average down on XBiotech Inc. stockMarket Sentiment Summary & Fast Moving Trade Plans - mfd.ru
How ACP stock expands through international markets2025 Year in Review & Real-Time Buy Signal Alerts - mfd.ru
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageTime to Sell? - MarketBeat
Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania
Sentiment Recap: Can XBiotech Inc lead its sector in growth2025 Price Targets & Long Hold Capital Preservation Plans - baoquankhu1.vn
Aug Technicals: Will XBiotech Inc benefit from seasonalityJuly 2025 Patterns & Long-Term Capital Growth Ideas - baoquankhu1.vn
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving AverageWhat's Next? - MarketBeat
Highs Report: Is XBiotech Inc part of any major indexWeekly Profit Recap & Consistent Profit Alerts - baoquankhu1.vn
Market Moves: Is XBiotech Inc stock risky to hold nowPortfolio Return Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Xbiotech Inc (XBIT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.77%
0.25%
자본화:
|
볼륨(24시간):